Salim Dhanji
Director Ejecutivo en ME THERAPEUTICS HOLDINGS INC. .
Fortuna: 20 M $ al 30/04/2024
Cargos activos de Salim Dhanji
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Director/Miembro de la Junta | 09/03/2023 | - |
| Director Ejecutivo | 09/03/2023 | - |
Historial de carrera de Salim Dhanji
Antiguos cargos conocidos de Salim Dhanji.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Qu Biologics, Inc.
 Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Corporate Officer/Principal | 01/01/2009 | 01/01/2014 |
Formación de Salim Dhanji.
| University of British Columbia | Doctorate Degree |
Estadísticas
Internacional
| Canadá | 4 |
Operativa
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Salim Dhanji
- Experiencia
